Soligenix Inc. (NASDAQ:SNGX) Relative Strength Index (RSI) is 34.22, with weekly volatility at 7.38% and ATR at 0.09. The SNGX stock’s 52-week price range has touched low of $0.86 and a $2.99 high. Intraday shares traded counted 0.89 million, which was 46.62% higher than its 30-day average trading volume of 1.66M. Its shares traded lower over the last trading session, losing -4.43% on 05/25/21. The shares fell to a low of $0.963 before closing at $0.97. SNGX’s previous close was $1.01 while the outstanding shares total 36.82M. The firm has a beta of 1.33.
Investors have identified the Biotechnology company Soligenix Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $37.40 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Soligenix Inc. (SNGX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For SNGX, the company has in raw cash 30.54 million on their books with 0.4 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 31.28 million total, with 4.3 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record -0.42 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on SNGX sounds very interesting.
Is the stock of SNGX attractive?
In related news, Director, ZELDIS JEROME B bought 3,000 shares of the company’s stock in a transaction that recorded on May 14. The purchase was performed at an average price of 0.89, for a total value of 2,664. As the purchase deal closes, the Director, ZELDIS JEROME B now sold 3,000 shares of the company’s stock, valued at 2,701. In the last 6 months, insiders have changed their ownership in shares of company stock by 2.87%.